Page 220 - Multidisipliner Covid 19
P. 220
BÖLÜM 12
KAYNAKLAR
1. Fauci AS, Lane HC, Redfield RR. Covid-19 - navigating the uncharted.
N Engl J Med. 2020;382(13):1268–9.
2. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic
treatments for coronavirus disease 2019 (COVID-19) a review. JAMA.
2020. https://doi.org/10.1001/jama.2020.6019. [Epub ahead of print].
3. Clinical management of severe acute respiratory infection when COVID-
19 is suspected 2020 [Internet]. World Health Organization [erişim 31
Mart 2020]. https://www.who.int/publications-detail/clinical- manage-
ment-of-severe-acute-respiratory-infection-when-novel-coronavirus-
(ncov)-infection-is-suspected.
4. Bhimraj A, Morgan RL, Shumaker AH, et al. Infectious Diseases Society
of America guidelines on the treatment and Management of Patients
with COVID-19 [Internet] [erişim 11 Mayıs 2020].https://www.idsociety.org/
practice-guideline/covid-19- guideline-treatment-and-management/.
5. COVID-19 Rehberi [Internet]. T.C. Sağlık Bakanlığı [erişim 25 Mayıs
2020]. https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID19_
Rehberi.pdf?type=file.
6. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chlo-
roquine on viral infections: an old drug against today’s diseases? Lan-
cet Infect Dis. 2003;3(11):722-727. doi:10.1016/S1473-3099(03) 00806-5.
7. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively
inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Cell Res. 2020;30(3):269–71.
8. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of
optimized dosing Design of Hydroxychloroquine for the treatment of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin
Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa237.
9. Zhou D, Dai SM, Tong Q. COVID-19: a recommendation to examine
the effect of hydroxychloroquine in preventing infection and progres-
sion. [published online March 20, 2020]. J Antimicrob Chemother. 2020;
dkaa114. doi:10. 1093/jac/dkaa114;
10. Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antivi-
ral effects of chloroquine against coronavirus: what to expect for COV-
ID-19? Int J Antimicrob Agents. 2020; 105938. doi:10.1016/j. ijantimicag.
2020.105938.
219